BIOMAT Database Logo BIOMAT Database Logo

Immunologic reactivity in patients with primary operable breast cancer. 1978

H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001941 Breast Diseases Pathological processes of the BREAST. Endocrine Breast Diseases,Breast Disease,Breast Disease, Endocrine,Breast Diseases, Endocrine,Disease, Breast,Disease, Endocrine Breast,Diseases, Breast,Diseases, Endocrine Breast,Endocrine Breast Disease
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast

Related Publications

H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
[Immunologic reactivity of breast cancer patients].
January 1978, Voprosy onkologii,
H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
Primary chemotherapy in operable breast cancer.
August 1996, Seminars in oncology,
H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
Immunologic reactivity and prognosis in breast cancer.
October 1980, Cancer,
H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
Staging imaging in women with primary operable breast cancer.
April 2005, Clinical radiology,
H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
Primary therapy of operable breast cancer.
January 1975, Connecticut medicine,
H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
Primary treatment for operable breast cancer.
January 1960, Proceedings. National Cancer Conference,
H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
Primary systemic therapy in operable breast cancer.
April 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
Breast cancer subtypes and survival in chinese women with operable primary breast cancer.
June 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu,
H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
[Use of tamoxifen in elderly patients with primary operable cancer of the breast].
January 1987, Sovetskaia meditsina,
H J Wanebo, and H T Thaler, and J A Hansen, and P P Rosen, and G F Robbins, and J A Urban, and H F Oettgen, and R A Good
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.
August 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!